BlackRock, Inc. 13D and 13G filings for Acorda Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2020-07-10 10:39 am Sale |
2020-06-30 | 13G | Acorda Therapeutics, Inc. ACOR |
BlackRock Inc. BLK |
9,544 2.400% |
-17,460![]() (-64.66%) |
Filing |
2020-06-09 4:32 pm Sale |
2020-05-31 | 13G | Acorda Therapeutics, Inc. ACOR |
BlackRock Inc. BLK |
27,004 6.800% |
-38,322![]() (-58.66%) |
Filing |